AptarGroup(ATR) - 2025 Q3 - Earnings Call Presentation

Financial Performance - Q3 2025 reported sales grew by 6% to $961 million compared to $909 million in Q3 2024[7, 15] - Q3 2025 core sales growth was 1%[7] - Q3 2025 reported earnings per share (EPS) increased by 30% to $1.92, compared to $1.48 in Q3 2024[7, 16] - Q3 2025 adjusted EPS grew by 4% to $1.62, compared to $1.56 in Q3 2024[7, 19] - Q3 2025 adjusted EBITDA increased by 7% to $223 million, compared to $208 million in Q3 2024[21] - Year-to-date 2025 reported sales increased by 3% to $2814 million, compared to $2735 million in the same period of 2024[33] - Year-to-date 2025 reported EPS increased by 17% to $4.75, compared to $4.05 in the same period of 2024[34] - Year-to-date 2025 adjusted EPS increased by 7% to $4.48, compared to $4.19 in the same period of 2024[38] - Year-to-date 2025 adjusted EBITDA increased by 8% to $624 million, compared to $580 million in the same period of 2024[40] Segment Performance - Aptar Pharma's Q3 2025 sales increased by 6%, with core sales up by 2%[24] - Aptar Beauty's Q3 2025 sales increased by 8%, with core sales flat at 0%[27] - Aptar Closures' Q3 2025 sales increased by 1%, with core sales down by 1%[30]